SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/D632494ECFD253E5EB4A41FF3582A7C5DBD0E685B4D0A6D20C74EC0B1660CA93AAEA38C01C44019DD317D6C2F7165085>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/D632494ECFD253E5EB4A41FF3582A7C5DBD0E685B4D0A6D20C74EC0B1660CA93AAEA38C01C44019DD317D6C2F7165085
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/D632494ECFD253E5EB4A41FF3582A7C5DBD0E685B4D0A6D20C74EC0B1660CA93AAEA38C01C44019DD317D6C2F7165085
http://www.w3.org/2000/01/rdf-schema#comment
"Data presented here indicate that endogenous HER-2/neu-specific humoral and T-cell immunity is greater in patients with +3 protein overexpression in their tumors than in patients with lower levels of HER-2/neu expression"
xsd:string
http://purl.uniprot.org/uniprot/#_434326C885E61908FFDA91135B0030CD1A6C4EBCED49D7AAAF36AEABA7819E28C315573947ED8CE2C079B8D6D74184A8
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/D632494ECFD253E5EB4A41FF3582A7C5DBD0E685B4D0A6D20C74EC0B1660CA93AAEA38C01C44019DD317D6C2F7165085
http://purl.uniprot.org/uniprot/P04626
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/D632494ECFD253E5EB4A41FF3582A7C5DBD0E685B4D0A6D20C74EC0B1660CA93AAEA38C01C44019DD317D6C2F7165085
http://purl.uniprot.org/uniprot/#_P04626-mappedCitation-18319334
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/D632494ECFD253E5EB4A41FF3582A7C5DBD0E685B4D0A6D20C74EC0B1660CA93AAEA38C01C44019DD317D6C2F7165085